Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids

American Journal of Clinical Nutrition

Volumn 69, Issue 1, 1999, Pages 127-134

  Kalivianakis, Mini ^b   Minich, Deanna M ^b   Bijleveld, Charles M A ^b   Van Aalderen, Wim M C ^b   Stellaard, Frans ^b   Laseur, Marianne ^b   Vonk, Roel J ^b   Verkade, Henkjan J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

Breath test; Children; Cystic fibrosis; Fat balance; Fat malabsorption; Lipolysis; Long chain fatty acids; Mixed triacylglycerol; Recommended dietary allowance; Stable isotopes; 13C linoleic acid

Indexed keywords

CARBON DIOXIDE; FAT; FECES LIPID; GLYCEROL DERIVATIVE; LINOLEIC ACID; LONG CHAIN FATTY ACID; STABLE ISOTOPE;

ADOLESCENT; ADULT; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CYSTIC FIBROSIS; ENZYME REPLACEMENT; FEMALE; HUMAN; LIPID ABSORPTION; MALABSORPTION; MALE; NUTRITIONAL REQUIREMENT; SCHOOL CHILD;

EID: 0032919630     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/69.1.127     Document Type: Article

References (52)

1. Carey MC, Hernell O. Digestion and absorption of fat. Semin Gastrointest Dis 1992;3:189-208.
2. Tso P. Intestinal lipid absorption. In: Johnson LR, ed. Physiology of the gastrointestinal tract. 3rd ed. New York: Raven Press. 1994:1867-907.
3. Staggers JE, Hernell O, Stafford RJ, Carey MC. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry 1990;29:2028-40.
4. Hernell O, Staggers JE, Carey MC. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry 1990;29:2041-56.
5. Pencharz PB, Durie PR. Nutritional management of cystic fibrosis. Annu Rev Nutr 1993;13:111-36.
6. Shalon LB, Adelson JW. Cystic fibrosis. Gastrointestinal complications and gene therapy. In: Lebenthal E. ed. The pediatric clinics of North America. Pediatric gastroenterology I. Philadelphia: WB Saunders Company, 1996:157-96.
7. Zentler-Munro PL, Fine DR, Batten JC, Northfield TC, Effect of cimetidine on enzyme inactivation. bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis. Gut 1985;26:892-901.
8. Regan PT, Malagelada J-R, DiMagno EP, Go VLW. Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: correction by treatment. Gastroenterology 1979;77:285-9.
9. Carroccio A, Pardo F, Montalto G. et al. Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy. A long-term study in cystic fibrosis. Dig Dis Sci 1992;37:1441-6.
10. Abrams CK, Hamosh M, Hubbard VS, Dutta SK, Hamosh P. Lingual lipase in cystic fibrosis. Quantitation of enzyme activity in the upper small intestine of patients with exocrine pancreatic insufficiency. J Clin Invest 1984;73:374-82.
11. Weber AM, Roy CC. Intraduodenal events in cystic fibrosis. J Pediatr Gastroenterol Nutr 1984;3(suppl):S113-9.
12. Robinson PJ, Smith AL, Sly PD, Duodenal pH in cystic fibrosis and its relationship to fat malabsorption. Dig Dis Sci 1990;35: 1299-304.
13. Robinson P, Sly P. High dose pancreatic enzymes in cystic fibrosis. Arch Dis Child 1990;65:311-2.
14. Smyth R, Van Velzen D, Smyth A, Lloyd D, Heaf D, Strictures of ascending colon in cystic fibrosis and high strength pancreatic enzymes. Lancet 1994;343:85-6.
15. MacSweeney E, Oades PJ, Buchdahl RM, Phelan M, Bush A. Relationship of thickening of colon wall to pancreatic enzyme treatment in cystic fibrosis. Lancet 1995;345:752-6.
16. FitzSimmons SC, Burkhart GA, Borowitz D, et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997;336:1283-9.
17. Zentler-Munro PL, FitzPatrick WJF, Batten JC, Northfield TC. Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis. Gut 1984;25:500-7.
18. Watkins JB, Tercyak AM, Szczepanik P, Klein PD. Bile salt kinetics in cystic fibrosis: influence of pancreatic enzyme replacement. Gastroenterology 1977;73:1023-8.
19. Roy CC, Weber EA, Morin CL, et al. Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes. N Engl J Med 1977;297:1301-5.
20. Belli DC, Levy E, Darling P, Leroy C, Lepage G. Taurine improves the absorption of a fat meal in patients with cystic fibrosis. Pediatrics 1987;80:517-23.
21. Eggermont E, De Boeck K. Small intestinal abnormalities in patients with cystic fibrosis. Eur J Pediatr 1991;150:824-8.
22. Corey M. McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583-91.
23. Vantrappen GR, Rutgeerts PJ, Ghoos YF, Hiele MI. Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterology 1989;96:1126-34.
24. 2 response. Eur J Clin Invest 1997;27:434-42.
25. 13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child 1997;76:349-51.
26. 13C-mixed triglyceride breath test in healthy controls and adult cystic fibrosis patients with exocrine pancreatic insufficiency. Digestion 1997;58:415-20.
27. 13C-labeled lipids: trioctanoin, triolein and palmitic acid breath tests. Gastroenterology 1982;82:911-7.
28. 13C-linoleic acid absorption test detects lipid malabsorption due to impaired solubilization in rats. Gastroenterology 1997;112(suppl):A894 (abstr).
29. Kerem B-S, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80.
30. Gerver WJM, De Bruin R. Paediatric morphometrics: a reference manual. Utrecht, Netherlands: Bunge, 1996.
31. Zapletal A. Samánek M, Paul T. Lung function in children and adolescents. Methods, reference values. Basel, Switzerland: Karger, 1987.
32. Anonymous. NEVO tabel. Nederlands Voedingstoffenbestand. (NEVO table. Dutch nutrient database.) Den Haag, Netherlands: Voorlichtingsbureau voor de Voeding, 1993 (in Dutch).
33. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986;27:114-20.
34. Van de Kamer JH, Ten Bokkel Huinink H, Weyers HA. Rapid method for the determination of fat in feces. J Biol Chem 1949;177:347-55.
35. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-7.
36. Murphy GM, Billing BH, Baron DN. A fluorimetric and enzymatic method for the estimation of serum total bile acids. J Clin Pathol 1970;23:594-8.
37. Kalek H-D, Stellaard F, Kruis W, Paumgartner G. Detection of increased bile acid excretion by determination of bile acid content in single stool samples. Clin Chim Acta 1984;140:85-90.
38. Eder K. Gas chromatography analysis of fatty acid methyl esters. J Chromatogr B 1995;671:113-31.
39. Gutnikov G. Fatty acid profiles of lipid samples. J Chromatogr B 1995;671:71-89.
40. 13C]palmitate. J Lipid Res 1997;38:1888-95.
41. Newcomer AD, Hofmann AF, DiMagno EP, Thomas PJ, Carlson GL. Triolein breath test: a sensitive and specific test for fat malabsorption. Gastroenterology 1979;76:6-13.
42. 14C-triolein breath test as a rapid and convenient screening test for fat malabsorption. Scand J Gastroenterol 1983;18:9-12.
43. Mills PR, Horton PW, Watkinson G. The value of the 14C breath test in the assessment of fat absorption. Scand J Gastroenterol 1979;14:913-21.
44. Carey MC, Small DM, Bliss CM. Lipid digestion and absorption. Annu Rev Physiol 1983;45:651-77.
45. Fomon SJ, Ziegler EE, Thomas LN, Jensen RL, Filer LJ Jr. Excretion of fat by normal full-term infants fed various milks and formulas. Am J Clin Nutr 1970;23:1299-313.
46. 14C]-triolein breath test is not valid as a test of fat absorption. Scand J Clin Lab Invest 1991;51:699-703.
47. Minich DM, Vonk RJ, Verkade HJ. Intestinal absorption of essential fatty acids under physiological and essential fatty acid-deficient conditions. J Lipid Res 1997;38:1709-21.
48. O'Brien S, Mulcahy H, Fenlon H, et al. Intestinal bile acid malabsorption in cystic fibrosis. Gut 1993;34:1137-41.
49. Weber AM, Roy CC, Morin CL, Lasalle R. Malabsorption of bile acid in children with cystic fibrosis. N Engl J Med 1973; 289:1001-5.
50. Weber AM, Roy CC, Chartrand L. Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis. Gut 1976;17:295-9.
51. Duncan A, Cameron A, Stewart MJ, Russell RI. Limitations of the triolein breath test. Clin Chim Acta 1992;205:51-64.
52. 13C-labeled stearic, oleic, and linoleic acids in humans: application to breath tests. J Lab Clin Med 1985;105:647-52.